Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.8054
+0.0031 (0.39%)
At close: Jul 2, 2025, 4:00 PM
0.7980
-0.0074 (-0.92%)
After-hours: Jul 2, 2025, 7:44 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $6.78 million as of July 2, 2025. Its market cap has decreased by -84.15% in one year.
Market Cap
6.78M
Enterprise Value
10.08M
1-Year Change
-84.15%
Ranking
Category
Stock Price
0.81
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $6.78M, a decrease of -95.44%. That is a compound annual growth rate of -51.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 6.75M | 109.52% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |